Epicor® postbiotic
EpiCor® is a yeast fermentation-derived postbiotic ingredient clinically shown to support immune and gut health, and is the #1 postbiotic ingredient globally by number of finished products formulated.
Overview
EpiCor is produced through a proprietary fermentation process using Saccharomyces cerevisiae. The resulting dried fermentate contains a complex matrix of metabolites, proteins, polyphenols, and beta-glucans that have demonstrated immunomodulatory and prebiotic activity in human clinical trials. Over 15 peer-reviewed studies support its efficacy for immune health, gut microbiome modulation, and upper respiratory health. The ingredient is FDA GRAS, heat-stable, pH-tolerant, and carries a three-year shelf life.
Technical specifications
- Source organism: Saccharomyces cerevisiae dried fermentate
- Clinical evidence: 15+ peer-reviewed human studies covering immune health, gut microbiome, and upper respiratory outcomes
- Regulatory: FDA GRAS
- Stability: heat-stable, pH-tolerant, three-year shelf life
- Dosage: 500mg/day (standard clinical dose)
- Formats: capsules, tablets, gummies, powdered beverages, bars, and functional food applications
- Market position: #1 postbiotic ingredient globally by number of formulated products
Technology readiness level
TRL 9 — fully commercialized with extensive clinical validation and global distribution.
About Cargill
Cargill is a global leader in agricultural, food, and industrial products, with a strong focus on sustainability and innovation in bio-based solutions.
delivered to your inbox.